Delphine Diagnostics continues to advance its mission of improving infection diagnosis and treatment decision support through innovation.
Beginning in Q1 2026, the company will collaborate with a New Jersey-based health network to retrain its AI and Machine Learning predictive models using more recent clinical datasets, further strengthening its capabilities in sepsis decision support.
As 2025 comes to a close, Delphine Diagnostics thanks its employees, consultants, advisors, and design partners for their contributions throughout the year and looks forward to continued innovation and growth in 2026.